Hematological parameters in hepatocellular carcinoma AND microRNA-223 gene associated with Hepatitis virus in local area

Cover Page

Cite item

Full Text

Abstract

Background. Hepatocyte function may be altered by chronic HBV and HCV infections through similar mechanisms that influence the onset of hepatocellular cancer. This current work points to examine the function of microRNA-223 in Iraqi hepatocellular carcinoma (HCC) patients induced by hepatitis virus. MicroRNA-223 served as calibrator to explores its evaluate disease progression and diagnosis. Materials and methods. Blood samples were then drawn from 20 people (males and females and different ages), some of them were latterly diagnosed with HCC. these blood samples were used later for molecular study to find target gene expression. Results. The importance of HCV, HBV, and liver cancer was examined in this study, along with the drop in research and studies conducted in Iraq. Those who got treatment had somewhat higher levels of microRNA-223 countenance, whereas those who were diagnosed early and did not get treatment had lower levels. MicroRNA-223 appearance stages were meaningfully lower in the first phase of hepatitis samples than in standard samples (p < 0.0001), which may indicate that microRNA-223 can be used as a biomarker to monitor conduct effectiveness. It is recommended that more research done in this area to help in diagnosis. Conclusion. MicroRNAs are an essential tool for early diagnosis and for monitoring the onset and progression of disease due to their great specificity and reliability. all results hat HCC patients with HBV and HCV expressed miR-223 at lower levels than healthy controls. Some hematological and parameters differed significantly from those in the control group.

About the authors

M. S. Al-Janaby

College of Science, University of Anbar

Email: rana2011@uoanbar.edu.iq

PhD, доцент кафедры биотехнологии, факультет естественных наук

Iraq, Al-Anbar

R. H. Abdujaleel

College of Science, University of Anbar

Email: rana2011@uoanbar.edu.iq

PhD, Lecturer, Department of Biotechnology

Iraq, Al-Anbar

M. A. Najm

College of Medicine, Ibn Sina University of Medical and Pharmaceutical Sciences

Email: rana2011@uoanbar.edu.iq

PhD, Assistant Professor, Department of Pharmacology

Iraq, Baghdad

Rana Talib Mohsen

College of Science, University of Anbar

Author for correspondence.
Email: rana2011@uoanbar.edu.iq

PhD, Assistant Professor, Department of Biotechnology

Iraq, Al-Anbar

A. K. Alalwani

College of Science, University of Anbar

Email: rana2011@uoanbar.edu.iq

Assistant Lecturer, Department of Biotechnology

Iraq, Al-Anbar

References

  1. Abosaooda M., Bahir H., Ali Salman N., Kamil Abbood S., Yassen Qassem L., Kadhim Jassem I.A., Ayyed Najm M., Soleymanabadi H. Evaluate the potential utilisation of B3S monolayer as a novel formaldehyde gas sensor. Mol. Phys., 2023, vol. 122, no. 12: e2294154. doi: 10.1080/00268976.2023.2294154
  2. Calin G.A., Croce C.M. MicroRNA signatures in human cancer. Nat. Rev. Cancer, 2006, vol. 6, no. 11, pp. 857–866. doi: 10.1038/nrc1997
  3. Cione E., Abrego Guandique D.M., Caroleo M.C., Luciani F., Colosimo M., Cannataro R. Liver damage and microRNAs: An Update. Curr. Issues Mol. Biol., 2023, vol. 45, no. 1, pp. 78–91. doi: 10.3390/cimb45010006
  4. Daghman B., Kaddar N., Najm M.A., Barakat H. Comparison of double dose of Paracetamol tablets 500mg with one Paracetamol tablet 1000mg. Res. J. Pharm. Technol., 2024, vol. 17, no. 10, pp. 4671–4676. doi: 10.52711/0974-360X.2024.00720
  5. Dong Y.W., Wang R., Cai Q.Q., Qi B., Wu W., Zhang Y.H., Wu X.Z. Sulfatide epigenetically regulates miR-223 and promotes the migration of human hepatocellular carcinoma cells. J. Hepatol., 2014, vol. 60, no. 4, pp. 792–801. doi: 10.1016/j.jhep.2013.12.004
  6. Fanning G.C., Zoulim F., Hou J., Bertoletti A. Therapeutic strategies for hepatitis B virus infection: towards a cure. Nat. Rev. Drug Discov., 2019, vol. 18, no. 11, pp. 827–844. doi: 10.1038/s41573-019-0037-0
  7. Faramin Lashkarian M., Hashemipour N., Niaraki N., Soghala S., Moradi A., Sarhangi S., Hatami M., Aghaei-Zarch F., Khosravifar M., Mohammadzadeh A., Najafi S., Majidpoor J., Farnia P., Aghaei-Zarch S.M. MicroRNA-122 in human cancers: from mechanistic to clinical perspectives. Cancer Cell Int., 2023, vol. 23, no. 1: 29. doi: 10.1186/s12935-023-02868-z
  8. Gu J., Xu H., Chen Y., Li N., Hou X. MiR-223 as a Regulator and Therapeutic Target in Liver Diseases. Front. Immunol., 2022, vol. 13: 860661. doi: 10.3389/fimmu.2022.860661
  9. Hassan S., Mohsen R.T., Farman S. Interleukin-37 gene single nucleotide polymorphisms and patient susceptibility to hepatitis B and C infection. Opera Med. Physiol., 2024, vol. 11, no. 1, pp. 52–60. doi: 10.24412/2500-2295-2024-1-52-60
  10. Hussein M.U., Mohsen R.T. Ambient Decontamination by Non-Thermal Plasma in Atmospheric Pressure Air. J. Phys.: Conf. Ser., 2017, vol. 1032, no. 1: 012032. doi: 10.1088/1742-6596/1032/1/012032
  11. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J. Clin., 2011, vol. 61, no. 2, pp. 69–90. doi: 10.3322/caac.20107
  12. Kennedy K., Graham S.M., Arora N., Shuhart M.C., Kim H.N. Hepatocellular carcinoma among US and non-US-born patients with chronic hepatitis B: Risk factors and age at diagnosis. PLoS One, 2018, vol. 13, no. 9: e0204031. doi: 10.1371/journal.pone.0204031
  13. Kisseleva T., Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat. Rev. Gastroenterol. Hepatol., 2021, vol. 18, no. 3, pp. 151–166. doi: 10.1038/s41575-020-00372-7
  14. Mohsen R.T., Al-Azzawi R.H., Ad’hiah A.H. Hepatitis B virus genotypes among chronic hepatitis B patients from Baghdad Iraq and their impact on liver function. Gene Rep., 2019, vol. 17: 100548. doi: 10.1016/j.genrep.2019.100548
  15. Mohsen R.T., Al-Azzawi R.H., Adhiah A.H. Serum level of interleukin-35 in patients with chronic hepatitis B virus infection. Iraqi J. Sci., 2020, vol. 61, no. 11, pp. 2860–2865. doi: 10.24996/ijs.2020.61.11.9
  16. Mohsen R.T., Al-Azzawi R.H., Adhiah A.H. Single-nucleotide polymorphism of IL12A gene (rs582537 A/C/G) and susceptibility to chronic hepatitis B virus infection among Iraqi patients. Egypt. J. Med. Hum. Genet., 2022, vol. 23, no. 1: 1-3. doi: 10.1186/s43042-022-00322-9
  17. Mohsen R., Al-Taee Z., Hussien Habeeb W., Abd-Alazeez R., Hassan S., Mohsen S. microRNA-122 gene expression in Iraqi patients with hepatocellular carcinoma. Asia-Pac. J. Mol. Biol. Biotechnol., 2024, vol. 32, no. 4, pp. 245–250. doi: 10.35118/apjmbb.2024.032.4.25
  18. Mohsen R., Khudhair I., Alkubaisi M., Al-Taee Z., Hussien Habeeb W., Hassan S. Hepatitis virus-related microRNA-122 gene and biochemical parameters in Iraqi patients with hepatocellular carcinoma. Egypt. J. Med. Microbiol., 2025, vol. 34, no. 1, pp. 141–148. doi: 10.21608/ejmm.2024.317083.1324
  19. Nasir G., Najm M., Mahmood H. Association Between Silver Nanoparticle Dose and Brain or Renal NF-κB Gene Expression. J. Nanostruct., 2025, vol. 15, no. 1, pp. 249–254. doi: 10.22052/JNS.2025.01.024
  20. Nasir G.A., Khudhair I.A., Najm M.A., Mahmood H.M. Nanotechnology at the Molecular Level. Al-Rafidain J. Med. Sci., 2022, vol. 3, pp. 71–74. doi: 10.54133/ajms.v3i.88
  21. Ogunwobi O.O., Harricharran T., Huaman J., Galuza A., Odumuwagun O., Tan Y., Nguyen M.T. Mechanisms of hepatocellular carcinoma progression. World J. Gastroenterol., 2019, vol. 25, no. 19, pp. 2279–2293. doi: 10.3748/wjg.v25.i19.2279
  22. Ormancey M., Thuleau P., Combier J.P., Plaza S. The Essentials on microRNA-Encoded Peptides from Plants to Animals. Biomolecules, 2023, vol. 13, no. 2: 206. doi: 10.3390/biom13020206
  23. Ryerson A.B., Schillie S., Barker L.K., Kupronis B.A., Wester C. Vital signs: newly reported acute and chronic hepatitis C Cases —United States, 2009–2018. Morb. Mortal. Wkly Rep., 2020, vol. 69, no. 14: 399.
  24. Sartorius K., Makarova J., Sartorius B., An P., Winkler C., Chuturgoon A., Kramvis A. The regulatory role of microRNA in hepatitis-B virus-associated hepatocellular carcinoma (HBV-HCC) pathogenesis. Cells, 2019, vol. 8, no. 12: 1504. doi: 10.3390/cells8121504
  25. Tarocchi M., Polvani S., Marroncini G., Galli A. Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis. World J. Gastroenterol., 2014, vol. 20, no. 33, pp. 11630–11640. doi: 10.3748/wjg.v20.i33.11630
  26. Wong Q.W., Lung R.W., Law P.T., Lai P.B., Chan K.Y., To K.F., Wong N. MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. Gastroenterology, 2008, vol. 135, no. 1, pp. 257–269. doi: 10.1053/ j.gastro.2008.04.003
  27. Xiaoyue L., Shujie L., Yongxiang Y. Research progress in hepatocellular carcinoma associated with hepatitis B virus and hepatitis C virus. Electron. J. Emerg. Infect. Dis., 2022, vol. 7, no. 1: 92.
  28. Ye D., Zhang T., Lou G., Liu Y. Role of miR-223 in the pathophysiology of liver diseases. Exp. Mol. Med., 2018, vol. 50, no. 9, pp. 1–12. doi: 10.1038/s12276-018-0153-7
  29. Yuan S., Wu Q., Wang Z., Che Y., Zheng S., Chen Y., Shi F. miR-223: An immune regulator in infectious disorders. Front. Immunol., 2021, vol. 12: 781815. doi: 10.3389/fimmu.2021.781815

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2025 Al-Janaby M.S., Abdujaleel R.H., Najm M.A., Mohsen R.T., Alalwani A.K.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).